Please login to the form below
respiratory
This page shows the latest respiratory news and features for those working in and with pharma, biotech and healthcare.
Latest news
-
AZ’s Sean Bohen to exit after business overhaul; report
company restructured around two divisions – cancer and biopharmaceuticals including cardiovascular, diabetes and respiratory drugs.
-
GSK upbeat on its return to oncology market
GSK faces generic competition to its biggest seller, ageing respiratory treatment Advair, by the end of 2019, and analysts believe the company’s HIV franchise could decline thanks to competition from ... Nevertheless, there is expected to be strong
-
Moderna CEO makes case for firm’s lofty valuation
studies of candidates for respiratory syncytial virus (RSV) and a personalised cancer vaccine partnered with Merck &Co/MSD also at the planning stage.
-
AstraZeneca unveils reorg, hires controversial José Baselga as cancer chief
cancer and another on biopharmaceuticals including cardiovascular, diabetes and respiratory drugs.
-
Circassia seeks shift to AIM after failing LSE criteria
and switching its focus to respiratory medicines.
More from news
Approximately 25 fully matching, plus 502 partially matching documents found.
Latest Intelligence
-
New models of NHS care – new models of pharma response?
The region is now adopting population health models for musculoskeletal (MSK) respiratory disease, diabetes and cardiovascular disease.
-
Deal Watch October 2018
Next the respiratory portfolio of GSK may be on the block after a widely reported comment by Alex Hoos, the head of oncology at GSK. ... The suggestion was that the strategic focus of GSK will be directed towards growth areas and that the respiratory
-
Lonely planet: why there is dwindling value in pharma travelling alone
An example is the real-world observational study GSK conducted for its respiratory treatment Relvar prior to regulatory approval.
-
China: AstraZeneca’s new engine for growth and innovation
He says the company is “very confident” of sustaining growth in China, and says its broad portfolio of medicines across oncology, respiratory and cardiovascular, metabolic and renal will help it achieve ... world. The company has what it calls a
-
Cancer immunotherapy: What's on the horizon?
They are also associated with a range of immune-related adverse effects involving the skin, gastrointestinal system, lungs, endocrine system and respiratory system.
More from intelligence
Approximately 0 fully matching, plus 69 partially matching documents found.
Latest appointments
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO
Under Bahija’s leadership, MedImmune significantly boosted its pipeline, expanding from 40 to more than 130 molecules in research and development targeting cancer; respiratory, inflammation, and autoimmunity; cardiovascular, renal and metabolic;
-
Alexion appoints new senior VP for EMEAC region
Her expertise lies in a range of therapeutic areas such as cardiovascular, diabetes, respiratory, ophthalmology and oncology.
-
Philips promotes Simon McGuire to health systems lead
He was previously GM at Philips Respironics Respiratory Drug Delivery. Technology company Philips has appointed Simon McGuire as its health systems lead for the UK and Ireland, reporting directly to chief ... McGuire was previously Philips' general
-
Makara Health appoints new associate director Helena Wright
She has previously held roles with GSK - where she worked on vaccines, respiratory and corporate communications - and Alliance Healthcare.
-
Teva's Mark Salyer joins Amarin
He joins the Irish biopharma company from Teva, where he served as general manager of its US respiratory division, and prior to that he held senior roles at GlaxSmithKline and Altana.
More from appointments
Approximately 0 fully matching, plus 46 partially matching documents found.
Latest from PMHub
-
Tracheal Tubes and Airway Products Market to Witness Soaring Growth During 2015-2025
rising incidence of chronic respiratory diseases, and increase in number of surgical procedures globally. ... Due to the large aging population and rise in the number of chronic respiratory diseases.
-
Portable Medical Devices Market Analysis, Trends and Future Outlook, Size, Strategies and Forecasts to 2028
The product attributes the company’s sleep and respiratory care management system. ... Blood Pressure Monitors. Blood Glucose Monitors. Blood Gas Monitors. Respiratory Monitoring Devices-.
-
Global Intraosseous Infusion Kits Market Industry Analysis Opportunity Assessment; 2018 - 2028
Intraosseous Infusion Kits Market: Drivers and Restraints. The increasing cases of trauma, respiratory failure or shock, circulatory collapse, ability to deliver the drug or fluid in large quantity and flow rate
-
Respiratory Inhaler Devices Market Set to Reach US$ 44,501.0 Mn By 2027
This in turn is expected to bolster respiratory inhaler devices market growth during the forecast period (2017–2027). ... Hence, patients with complex respiratory disorders are more inclined towards adopting such therapies.
-
Aromatherapy Market : Quantitative Market Analysis, Current and Future Trends, 2016-2026
Aromatherapy acts as a complementary treatment in many viral and bacterial diseases such as acute respiratory infections, viral infections, influenza, and bronchitis, and can be used during prophylactic and therapeutic treatment
More from PMHub
Approximately 1 fully matching, plus 31 partially matching documents found.
Featured jobs
-
Associate Director
-
£75, 000-90, 000
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
-
Account Manager / Account Director
-
Competative
-
Business Director
-
Competitive Salary Offered
-
Medical Writer
-
Salary TBC
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
Senior Account Manager
-
Competitive Salary Offered
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
-
Senior Medical Writer
-
Salary TBC
-
Account Director
-
Competitive Salary Offered
- Global Business Development Director – Health Education
-
excellent commission
-
Account Director, Medical Education
-
Salary TBC
Subscribe to our email news alerts
- Meet Porterhouse Medical at the ISMPP EU meeting 2019 in London 22 - 23 January
- Immunomedics craters after FDA rejects breast cancer ADC
- UK businesses leaning towards second Brexit vote
- NHS England sees off AbbVie's Hep C legal challenge
- China’s clinical trial shake-up
- Europe closer to biosimilar rule change, despite fierce resistance from pharma
PMHub
bmore group
OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....
Latest intelligence
- China’s clinical trial shake-up
- As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Healthcare leaders in the European Union should begin preparing for a breakthrough now...
- The UK’s new five-year pricing agreement
- Pharma has agreed to capped growth again - in exchange for uptake promises...
Quick links
Infographics
